Minapharm Pharmaceuticals is a leading pharmaceutical company in Egypt and the Middle East and the premier biopharmaceutical company in Africa with over 20 years of experience in cellular and bioprocess engineering. Headquartered in Cairo, Minapharm commercializes over 100 life-saving and life-enhancing products ranging from small molecules to complex genetically-engineered proteins, with an impressive immunotherapy pipeline. Together with its wholly owned Berlin-based subsidiary, ProBioGen, Minapharm has established an integrated business model making it to-date the only gene-to-market biopharmaceutical company in the region.
View Top Employees from Minapharm PharmaceuticalsWebsite | http://www.minapharm.com |
Revenue | $684 million |
Employees | 909 (486 on RocketReach) |
Founded | 1958 |
Address | El-Bardissi St 2T Takseem Asmaa Fahmy St, Cairo, Cairo, EG |
Phone | +20 2 24143170 |
Fax | +20 2 24143179 |
Technologies |
JavaScript,
HTML,
Google Analytics
+25 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Health Care, Pharmaceutical, Drug Discovery, Biopharmaceuticals, Healthcare |
Web Rank | 777584 |
Keywords | Pharmaceutical Products, Biopharmaceuticals, Small Molecule Drug Discovery, Bioprocessing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Minapharm Pharmaceuticals employee's phone or email?
The Minapharm Pharmaceuticals annual revenue was $684 million in 2024.
Wafik Bardissi is the Chairman and of Minapharm Pharmaceuticals.
486 people are employed at Minapharm Pharmaceuticals.
Minapharm Pharmaceuticals is based in Cairo, Cairo.
The NAICS codes for Minapharm Pharmaceuticals are [32541, 3254, 32, 325].
The SIC codes for Minapharm Pharmaceuticals are [28, 283].